GlaxoSmithKline's Kai Gait

Digital Pharma: A Year in Digital (2/5)

pharmafile | December 10, 2009 | Feature | Medical Communications 2009, GSK, digi, digital pharma, year in review 

Favourite use of digital (pharma)

Creative Lynx & Jansen-Cilag’s Concerta XL Tablet PC campaign

Favourite use of digital (non-pharma)

BBC iPlayer

Favourite social media initiative (pharma)

Boehringer and Twitter – a brave step forwards for pharma in a new channel

Favourite social media initiative (non-pharma)

Twitter – a brilliant way to share and collaborate but in a small space. Makes people cut out the waffle 😉

Most significant online event for pharma in 2009

The FDA social media event – for getting them to discuss openly

How would you summarise pharma’s use of ‘digital’ in 2009

A lot of the activities are very ‘same-old-stuff’, but a few companies pushed the boundaries in trying new channels.

A good leap forwards for those prepared to try!

Kai Gait is digital commerce marketing manager at GlaxoSmithKline. He is involved in developing innovative digital strategies and tools to engage with healthcare customers. Kai and the Digital Commerce team were recently behind the GSK UK product information website, health.gsk.co.uk.

Over the next week some of European pharma’s foremost digital exponents have kindly agreed to share their online highlights from the year. The series continues on Monday with Roche’s head of corporate internet and social media Sabine Kostevc.

Related Content

testalize-me-0je8ynv4mis-unsplash

GSK shares results from phase 3 trial for Blenrep as multiple myeloma treatment

GSK has announced positive results from a planned interim efficacy analysis of the phase 3 …

GSK’s low carbon inhaler, Ventolin, progresses to phase 3 trials 

GSK has announced that in 2024 it intends to start phase 3 trials of a …

testalize-me-0je8ynv4mis-unsplash

GSK gains positive CHMP opinion for momelotinib for myelofibrosis treatment

GSK has announced that the Committee for Medicinal Products for Human Use (CHMP) of the …

Latest content